SCHEMBL8196744

SCHEMBL8196744

Clc1ccc(-c2ccc3oc(-c4ccccc4C4=NCCN4)cc3c2)c(Cl)c1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NISCH Q9Y2I1 6/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ CYP1A2 P05177 2/20 0.49
▸ CYP2D6 P10635 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.49
▸ MAOA P21397 2/20 0.49
▸ MAOB P27338 2/20 0.49
▸ KDM4E B2RXH2 1/20 0.49
▸ ADRA2A P08913 1/20 0.49
▸ HPGD P15428 1/20 0.49
▸ ADRA2B P18089 1/20 0.49
▸ ADRA2C P18825 1/20 0.49
▸ PRMT1 Q99873 2/20 0.46
▸ PRMT3 O60678 1/20 0.46
▸ EHMT2 Q96KQ7 1/20 0.46
▸ PRMT6 Q96LA8 1/20 0.46
▸ PRMT8 Q9NR22 1/20 0.46
▸ RECQL P46063 2/20 0.43
▸ USP2 O75604 1/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8196630 0.89 NISCH (0.53) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL8200670 0.87 NISCH (0.53) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL8194569 0.83 NISCH (0.56) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL8198114 0.81 NISCH (0.54) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL8188905 0.80 NISCH (0.48) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL8188068 0.80 NISCH (0.50) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
Hydrochloric Acid SCHEMBL8197571 0.80 NISCH (0.46) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL8201878 0.79 NISCH (0.51) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL8198751 0.79 NISCH (0.54) NISCHALDH1A1CYP1A2CYP2D6HSD17B10
SCHEMBL8200508 0.78 NISCH (0.50) NISCHALDH1A1CYP1A2CYP2D6HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000078726-A1 IMIDAZOLINE DERIVATIVES FOR THE TREATMENT OF DIABETES, ESPECIALLY TYPE II DIABETES ELI LILLY AND COMPANY (US) 2000-12-28 — — WO disclosed
Send feedback